So MAPS embarked on a many years-extensive effort and hard work to prove that the drug experienced benefit being a drugs, elevating $one hundred forty million from donors to purchase scientific trials. The Corporation shaped precisely what is now Lykos ten years back as a general public-advantage Company, in anticipation that MDMA-assisted therapy